Cargando…
A retrospective analysis to estimate the healthcare resource utilization and cost associated with treatment-resistant depression in commercially insured US patients
OBJECTIVE: The economic burden of commercially insured patients in the United States with treatment-resistant depression and patients with non–treatment-resistant major depressive disorder was compared using data from the Optum Clinformatics™ claims database. METHODS: Patients 18–63 years on antidep...
Autores principales: | Li, Gang, Zhang, Ling, DiBernardo, Allitia, Wang, Grace, Sheehan, John J., Lee, Kwan, Reutfors, Johan, Zhang, Qiaoyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485754/ https://www.ncbi.nlm.nih.gov/pubmed/32915863 http://dx.doi.org/10.1371/journal.pone.0238843 |
Ejemplares similares
-
All-cause mortality in patients with treatment-resistant depression: a cohort study in the US population
por: Li, Gang, et al.
Publicado: (2019) -
Treatment‐resistant depression as risk factor for substance use disorders—a nation‐wide register‐based cohort study
por: Brenner, Philip, et al.
Publicado: (2019) -
Substance use disorders and risk for treatment resistant depression: a population‐based, nested case‐control study
por: Brenner, Philip, et al.
Publicado: (2019) -
Humanistic outcomes in treatment resistant depression: a secondary analysis of the STAR*D study
por: DiBernardo, Allitia, et al.
Publicado: (2018) -
A register-based approach to identifying treatment-resistant depression—Comparison with clinical definitions
por: Hägg, David, et al.
Publicado: (2020)